Akira Ema
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 11
-
- Gastric Cancer Management and Outcomes 21
- Metastasis and carcinoma case studies 10
-
- Esophageal Cancer Research and Treatment 9
- Esophageal and GI Pathology 8
-
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 7
- RNA modifications and cancer 4
Akira Ema
33 papers receiving 638 citations
Peers
Comparison fields: 5 of 65
- Gastroenterology 92
- Pulmonary and Respiratory Medicine 287
- Cancer Research 110
- Oncology 165
- Surgery 237
Countries citing papers authored by Akira Ema
This map shows the geographic impact of Akira Ema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Ema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Ema more than expected).
Fields of papers citing papers by Akira Ema
This network shows the impact of papers produced by Akira Ema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Ema. The network helps show where Akira Ema may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akira Ema, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 23 | |
| 2 | 2019 | 21 | |
| 3 | 2018 | 6 | |
| 4 | 2018 | 5 | |
| 5 | 2017 | 4 | |
| 6 | 2017 | 29 | |
| 7 | 2017 | 9 | |
| 8 | 2017 | 17 | |
| 9 | 2016 | 15 | |
| 10 | 2016 | 28 | |
| 11 | 2016 | 69 | |
| 12 | 2016 | 29 | |
| 13 | Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC. | 2015 | 22 |
| 14 | 2015 | 14 | |
| 15 | Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up. | 2014 | 13 |
| 16 | 2014 | 34 | |
| 17 | 2014 | 19 | |
| 18 | 2014 | 30 | |
| 19 | 2011 | 0 | |
| 20 | 2009 | 2 |
About Akira Ema
Akira Ema is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, having authored 35 papers that have together received 640 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (21 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Metastasis and carcinoma case studies (10 papers), Epigenetics and DNA Methylation (9 papers), Esophageal Cancer Research and Treatment (9 papers), Esophageal and GI Pathology (8 papers), Cancer-related gene regulation (7 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Gastroenterology (92 citations), Pulmonary and Respiratory Medicine (287 citations) and Cancer Research (110 citations). Akira Ema has collaborated with scholars based in Japan and United States. Frequent co-authors include Keishi Yamashita, Masahiko Watanabe, Kei Hosoda, Hiroaki Mieno, Hiromitsu Moriya, Hideki Ushiku, Mina Waraya, Masahiko Watanabe, Hiroshi Katoh and Natsuya Katada. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.